Steroid hormone APIs are built on a tetracyclic skeleton through 15–30 functional-group-intensive steps. Dimethyl sulfoxide appears at several of them: regioselective acetylation co-solvent, the source and medium for the Corey–Chaykovsky ylide, and a high-boiling medium for oxidation and lactone closure.
Reaction Mechanisms and Process Conditions
In the regioselective acetylation of dexamethasone, the DMSO/methanol/sodium methoxide system exploits differential hydroxyl reactivity: the C21 primary hydroxyl is more nucleophilic than the C11 and C17 secondary alcohols, and DMSO’s polar aprotic environment enhances methoxide reactivity while dissolving the steroid substrate. Temperature is held at 0–25 °C to favor mono-acetylation, and the reaction is quenched with acetic acid once HPLC shows full conversion of the C21 hydroxyl.
For the Corey–Chaykovsky epoxidation in eplerenone, trimethylsulfoxonium iodide is deprotonated by NaH in DMSO/THF at 0–25 °C to form dimethylsulfoxonium methylide, a stabilized ylide whose sulfoxide oxygen is inherited from DMSO. The ylide adds to the steroidal ketone carbonyl to form a betaine, which collapses with displacement of dimethyl sulfoxide to close the epoxide ring. The mixed DMSO/THF solvent balances ylide generation rate (faster in DMSO) with exotherm control (moderated by THF), and anhydrous conditions are essential because water quenches both NaH and the ylide.
Dexamethasone and the Corticosteroids
Dexamethasone is acetylated regioselectively at the C21 hydroxyl in a DMSO/methanol/sodium methoxide system, where DMSO dissolves the poorly soluble steroid and helps keep mono-acetylation rather than di- or tri-acetylation. Prednisolone and betamethasone use DMSO as a thermally stable medium at 120–180 °C for Δ¹-dehydrogenation and rearrangements, raising effective substrate concentration.
| API | Steroid class | Key DMSO application |
|---|---|---|
| Dexamethasone | Glucocorticoid | Regioselective acetylation co-solvent |
| Prednisolone | Glucocorticoid | Δ¹-dehydrogenation medium |
| Eplerenone | Antimineralocorticoid | Corey–Chaykovsky ylide source and solvent |
| Spironolactone | Antimineralocorticoid | Oxidation and 17-lactonization |
Table 1: DMSO applications across major steroid hormone APIs
Eplerenone and Spironolactone
Eplerenone carries a 9α,11α-epoxide installed by the Corey–Chaykovsky reaction, in which trimethylsulfoxonium iodide is deprotonated with NaH in a DMSO/THF mixture. DMSO is both the source of the sulfoxonium ylide and its stabilizing solvent, and the mild ylide suits the functionalized canrenone intermediate; the mixed DMSO/THF medium balances ylide stability and substrate solubility. Spironolactone uses DMSO to oxidize a hydroxyl to a ketone and to close the 17-lactone ring at elevated temperature.
Why DMSO over Alternatives
The eplerenone ylide cannot be generated in a solvent that reacts with NaH or quenches the ylide, and DMSO is effectively irreplaceable as the sulfoxonium source. For the corticosteroid dehydrogenations, DMSO’s high boiling point keeps the low-solubility steroid homogeneous at 120–180 °C where lower-boiling solvents require pressure equipment. Pharmaceutical-grade DMSO (USP <679>/EP 0429) with low water is used across GMP routes, and residuals are controlled under ICH Q3C Class 3.
References
- Corey, E.J.; Chaykovsky, M. J. Am. Chem. Soc., 1962, 84(5), 866–867.
- Pharmacia & Upjohn / Pfizer. U.S. Patent 5,981,748; 1999.
- ICH Harmonised Tripartite Guideline Q3C(R6), 2019.